An audit of Honolulu's homeless assistance program, CORE, has been halted due to frequent changes and unreliable data. The ...

A 12News investigation found the number of students receiving higher-paying special education vouchers has tripled in four ...

Estrella Resources’ exploration program in the southeast nation of Timor-Leste has unearthed two super high-grade samples of ...

Opus Genetics, Inc. (Nasdaq: IRD) (the “Company”, “Opus Genetics” or “Opus”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients ...

Clint Proctor is a managing editor with the credit cards and travel rewards team at Forbes Advisor. He has eight years of experience in personal finance journalism and has contributed to a variety of ...

On July 7, the Council of the District of Columbia took its second and final vote on the FY 2027 Budget Support Act (BSA), ...

A Labor frontbencher has conceded Australia needs “more skilled tradies in our country”, with both the Coalition and One ...

Sixty hospital C-suite leaders name their No. 1 H2 2026 priority. Access leads a list shaped by Medicaid cuts, AI and ...

When professors want to dispute cuts, they turn to Howard Bunsis. Is he just telling them what they want to hear?

Only 23% of the 1,200 people who participated in “Trust Divided,” a UC Irvine School of Ecology survey released last week ...

Good morning, The Padres had a night unlike many they have had all season and like no other game in more than two months.

Opus Genetics, Inc. (Nasdaq: IRD) (the "Company", "Opus Genetics" or "Opus"), a clinical-stage biopharmaceutical company developing gene ...